Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer : an update from the PIONEER Consortium
dc.contributor.author | Beyer, Katharina | |
dc.contributor.author | Moris, Lisa | |
dc.contributor.author | Lardas, Michael | |
dc.contributor.author | Omar, Muhammad Imran | |
dc.contributor.author | Healey, Jemma | |
dc.contributor.author | Tripatheed, Sheela | |
dc.contributor.author | Gandaglia, Giorgio | |
dc.contributor.author | Venderbos, Lionne DF | |
dc.contributor.author | Vradi, Eleni | |
dc.contributor.author | van den Broeck, Thomas | |
dc.contributor.author | Willemse, Peter-Paul M. | |
dc.contributor.author | Antunes-Lopes, Tiago | |
dc.contributor.author | Pacheco-Figueiredo, Luís | |
dc.contributor.author | Monagas Arteaga, Serenella | |
dc.contributor.author | Esperto, Francesco | |
dc.contributor.author | Flaherty, Stephen | |
dc.contributor.author | Devecseri, Zsuzsanna | |
dc.contributor.author | Lam, Thomas | |
dc.contributor.author | Williamson, Paula R. | |
dc.contributor.author | Heer, Rakesh | |
dc.contributor.author | Smith, Emma Jane | |
dc.contributor.author | Asiimwe, Alex | |
dc.contributor.author | Huber, Johannes | |
dc.contributor.author | Roobol, Monique J | |
dc.contributor.author | Zong, Jihong | |
dc.contributor.author | Mason, Malcolm D. | |
dc.contributor.author | Cornford, Philip | |
dc.contributor.author | Mottet, Nicolas | |
dc.contributor.author | MacLennan, Sara | |
dc.contributor.author | N'Dow, James | |
dc.contributor.author | Brigantii, Alberto | |
dc.contributor.author | MacLennan, Steven | |
dc.contributor.author | Van Hemelrijck, Mieke | |
dc.contributor.author | PIONEER Consortium | |
dc.date.accessioned | 2022-07-15T10:14:01Z | |
dc.date.available | 2022-07-15T10:14:01Z | |
dc.date.issued | 2022-05 | |
dc.identifier | 212222038 | |
dc.identifier | 3c81dc36-4740-45cd-a215-cd8caaf886f0 | |
dc.identifier | 85124810302 | |
dc.identifier | 85124810302 | |
dc.identifier.citation | Beyer , K , Moris , L , Lardas , M , Omar , M I , Healey , J , Tripatheed , S , Gandaglia , G , Venderbos , L DF , Vradi , E , van den Broeck , T , Willemse , P-P M , Antunes-Lopes , T , Pacheco-Figueiredo , L , Monagas Arteaga , S , Esperto , F , Flaherty , S , Devecseri , Z , Lam , T , Williamson , P R , Heer , R , Smith , E J , Asiimwe , A , Huber , J , Roobol , M J , Zong , J , Mason , M D , Cornford , P , Mottet , N , MacLennan , S , N'Dow , J , Brigantii , A , MacLennan , S , Van Hemelrijck , M & PIONEER Consortium 2022 , ' Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer : an update from the PIONEER Consortium ' , European Urology , vol. 81 , no. 5 , pp. 503-514 . https://doi.org/10.1016/j.eururo.2022.01.042 | en |
dc.identifier.issn | 0302-2838 | |
dc.identifier.other | ORCID: /0000-0003-1405-6964/work/116105487 | |
dc.identifier.other | ORCID: /0000-0002-2691-8421/work/116747626 | |
dc.identifier.other | ORCID: /0000-0002-1597-3126/work/116747699 | |
dc.identifier.uri | https://hdl.handle.net/2164/18876 | |
dc.description | Acknowledgements: We are thankful to all the patients and health care professionals who took part in our interview studies and to the patient representatives and advocates who provided insight during our various consensus meetings. We are grateful to Dr. Susie Dodd for her advice in applying the 38-item outcome taxonomy which she and her COMET colleagues developed, and we accept responsibility for any (mis)application. PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint under- taking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. | en |
dc.format.extent | 12 | |
dc.format.extent | 1095087 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Urology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Prostate Cancer | en |
dc.subject | Patient pathway | en |
dc.subject | Comparative effectiveness research | en |
dc.subject | Core outcome sets | en |
dc.subject | Standardised outcome sets | en |
dc.subject | Outcomes | en |
dc.subject | Randomized controlled trials | en |
dc.subject | Systematic reviews | en |
dc.subject | Big Data | en |
dc.subject | Real world Data | en |
dc.subject | R Medicine | en |
dc.subject | Urology | en |
dc.subject | European Commission | en |
dc.subject | 777492 | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R | en |
dc.title | Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer : an update from the PIONEER Consortium | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.1016/j.eururo.2022.01.042 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85124810302&partnerID=8YFLogxK | en |
dc.identifier.vol | 81 | en |
dc.identifier.iss | 5 | en |